Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05746143

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

Conditions: Spine Fusion, Lumbar Spine Degeneration, Pain, Postoperative, Lumbar Spine Spondylosis

Sex: All
Ages: 18 Years – 75 Years
Phase: NA
Enrollment: 140
Sponsor: University of Southern California

Location: United States

Summary

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

Eligibility Criteria

Inclusion Criteria:degenerative lumbar diseaseage of 18-75undergoing open primary one- to three-level lumbar fusionExclusion Criteria:currently use a sleep aid nightlydiagnosed with insomnia or sleep apneahistory of delirium with opiates or zolpidemallergic to opiates or zolpidemhad previous lumbar spine surgeryundergoing minimally invasive lumbar fusion,undergoing lumbar fusion for fracture, infection, tumor, or an inflammatory spondyloarthropathy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05746143). StuddyBuddy aggregates publicly available trial information.